NCT03168568View on ClinicalTrials.gov

Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction

PHASE4CompletedINTERVENTIONAL

Enrollment

79

Participants

Timeline

Start Date

May 4, 2017

Primary Completion Date

September 5, 2020

Study Completion Date

September 5, 2020

Conditions

Heart Failure

Interventions

DRUG

Valsartan/Sacubitril or placebo

tablet (double dummy)

DRUG

Valsartan or placebo

tablet (double dummy)

Trial Locations (1)

8091

University Heart Center Zurich, Zurich

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Zurich

OTHER